Back to top
more

Humana (HUM)

(Real Time Quote from BATS)

$255.12 USD

255.12
1,313,360

-5.59 (-2.14%)

Updated Nov 4, 2024 03:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (159 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Humana (HUM) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

Humana (HUM) closed the most recent trading day at $447.26, moving +1.48% from the previous trading session.

Teladoc (TDOC) & Microsoft Partner to Reduce Administrative Woes

by Zacks Equity Research

Teladoc (TDOC) collaborates with Microsoft, enabling automatic clinical documentation with the help of AI.

Acadia Healthcare's (ACHC) New Facility Boosts Pennsylvania Reach

by Zacks Equity Research

Acadia Healthcare (ACHC) commences operations at one of the two hospitals, which form a part of its JV with Geisinger. The company is committed to offer enhanced behavioral health services in Pennsylvania.

Will Humana (HUM) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks.com featured highlights include Humana, The TJX Companies, Sunstone Hotel Investors, Atmos Energy and MINISO Group Holding

by Zacks Equity Research

Humana, The TJX Companies, Sunstone Hotel Investors, Atmos Energy and MINISO Group Holding are part of the Zacks Screen of the Week article.

Humana (HUM) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Humana (HUM) closed at $424.29 in the latest trading session, marking a -0.19% move from the prior day.

Here's Why You Should Hold Centene (CNC) Stock for Now

by Zacks Equity Research

Strong membership growth, contract wins, accretive acquisitions and the streamlining of businesses poise Centene (CNC) well for growth.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Aparajita Dutta headshot

5 Low-Leverage Stocks to Buy as Inflation Cools Down Slightly

by Aparajita Dutta

The equity market can be volatile at times and as an investor, if you want to play safe, buy stocks like HUM, TJX, SHO, ATO and MNSO.

Are Options Traders Betting on a Big Move in Humana (HUM) Stock?

by Zacks Equity Research

Investors need to pay close attention to Humana (HUM) stock based on the movements in the options market lately.

The Zacks Analyst Blog Highlights Honeywell International, Humana, Keurig Dr Pepper, NextEra Energy and The Coca-Cola

by Zacks Equity Research

Honeywell International, Humana, Keurig Dr Pepper, NextEra Energy and The Coca-Cola are part of the Zacks top Analyst Blog.

Why You Should Add Humana (HUM) Stock to Your Portfolio Now

by Zacks Equity Research

Humana's (HUM) strength in Individual Medicare Advantage business and state-based contract wins are likely to be major tailwinds.

Nalak Das headshot

Buy 5 Underperformers of 1H That Are Set to Be on a Roll in 2H

by Nalak Das

We have narrowed our search to five U.S. corporate bigwigs with negative returns in stock prices in the first half of 2023. These are: HON, HUM, KO, KDP, NEE.

Humana (HUM) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Humana (HUM) closed the most recent trading day at $440.99, moving -0.9% from the previous trading session.

UnitedHealth's (UNH) Suffering Continues: Should You Hold Tight?

by Zacks Equity Research

Each sub-segment of Optum, UnitedHealth's (UNH) health service business, is expected to continue delivering a solid performance, driving the overall segment's growth.

Molina (MOH) to Buy Bright Health's California Medicare Business

by Zacks Equity Research

Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal plan.

Humana (HUM) Gains But Lags Market: What You Should Know

by Zacks Equity Research

Humana (HUM) closed at $447.13 in the latest trading session, marking a +0.74% move from the prior day.

Down -13.84% in 4 Weeks, Here's Why You Should You Buy the Dip in Humana (HUM)

by Zacks Equity Research

Humana (HUM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Is Humana (HUM) a Buy as Wall Street Analysts Look Optimistic?

by Zacks Equity Research

The average brokerage recommendation (ABR) for Humana (HUM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Should Value Investors Buy Humana (HUM) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

UnitedHealth Group (UNH) Expands Home Healthcare Business

by Zacks Equity Research

UnitedHealth Group (UNH) boosts home healthcare presence with the acquisition of Amedisys for $3.3 billion

UnitedHealth's (UNH) Optum Rx Makes Patient Care Affordable

by Zacks Equity Research

UnitedHealth Group, Inc's. (UNH) Optum Rx is set to offer three biosimilar alternatives for HUMIRA effective Jul 1, providing affordability in patient care.

Andrew Rocco headshot

Profiting from the 3rd Wave of the App Economy

by Andrew Rocco

The third wave of the application economy will be driven by the onset of VR headsets and Artificial Intelligence. Because of their partnerships with tech juggernauts, two companies stand to benefit the most.

Humana's (HUM) CenterWell Unit Plans to Expand in Tennessee

by Zacks Equity Research

Humana's (HUM) CenterWell business is likely to benefit from its promising plans to expand across middle Tennessee this year.

Here's Why Buying Brookdale (BKD) Stock is a Prudent Move Now

by Zacks Equity Research

For the second quarter, Brookdale (BKD) expects RevPAR growth to be in the range of 11.5-12%.